New patent expiration for Kowa Co drug LIVALO

Livalo, a drug marketed by Kowa Co, is protected by two patents and is facing one Paragraph IV challenge. The medication, which assists in controlling cholesterol, has its underlying generic ingredient as pitavastatin calcium. The drug is solely available from one supplier.